{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Applied Therapeutics, Inc."},"Symbol":{"label":"Symbol","value":"APLT"},"Address":{"label":"Address","value":"545 FIFTH AVENUE SUITE 1400, NEW YORK, New York, 10017, United States"},"Phone":{"label":"Phone","value":"+1 212 220-9226"},"Industry":{"label":"Industry","value":"Biotechnology: Pharmaceutical Preparations"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The lead product candidate of the company is AT-001, which is a novel ARI with broad systemic exposure and peripheral nerve permeability, developed for the treatment of diabetic cardiomyopathy, or DbCM, a fatal fibrosis of the heart."},"CompanyUrl":{"label":"Company Url","value":"https://www.appliedtherapeutics.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Riccardo Perfetti","title":"Chief Medical Officer"},{"name":"Shoshana Shendelman","title":"Chairman, President, CEO &amp; Secretary"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}